Selected research
Industry Research
Gene Service Industry Research Report 2026
Market perspective
The global Gene Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Gene Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Gene Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Gene Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Gene Service include LipExoGen Biotech, Synbio Technologies, Genscript Biotech Corporation, Creative Biogene, GENEWIZ, Bio-Techne, Charles River Laboratories, Geneservice and Boston Medical Center, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Gene Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Gene Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gene Service Market by Company
LipExoGen Biotech
Synbio Technologies
Genscript Biotech Corporation
Creative Biogene
GENEWIZ
Bio-Techne
Charles River Laboratories
Geneservice
Boston Medical Center
DefiGEN
NHS England
Integrated DNA Technologies
Blossom
Aldevron
Biocytogen
Gene Service Segment by Type
Gene Synthesis
Gene Cloning
Gene Mutagenesis
Gene Regulation
Gene Service Segment by Application
Medical
Biological
Gene Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Gene Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gene Synthesis
- Gene Cloning
- Gene Mutagenesis
- Gene Regulation
Applications
- Medical
- Biological
Companies covered
- LipExoGen Biotech
- Synbio Technologies
- Genscript Biotech Corporation
- Creative Biogene
- GENEWIZ
- Bio-Techne
- Charles River Laboratories
- Geneservice
- Boston Medical Center
- DefiGEN
- NHS England
- Integrated DNA Technologies
- Blossom
- Aldevron
- Biocytogen
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Gene Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Gene Synthesis
- 2.2.3 Gene Cloning
- 2.2.4 Gene Mutagenesis
- 2.2.5 Gene Regulation
- 2.3 Gene Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical
- 2.3.3 Biological
- 2.4 Assumptions and Limitations
3 Gene Service Breakdown Data by Type
- 3.1 Global Gene Service Historic Market Size by Type (2021-2026)
- 3.2 Global Gene Service Forecasted Market Size by Type (2027-2032)
4 Gene Service Breakdown Data by Application
- 4.1 Global Gene Service Historic Market Size by Application (2021-2026)
- 4.2 Global Gene Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Gene Service Market Perspective (2021-2032)
- 5.2 Global Gene Service Growth Trends by Region
- 5.2.1 Global Gene Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Gene Service Historic Market Size by Region (2021-2026)
- 5.2.3 Gene Service Forecasted Market Size by Region (2027-2032)
- 5.3 Gene Service Market Dynamics
- 5.3.1 Gene Service Industry Trends
- 5.3.2 Gene Service Market Drivers
- 5.3.3 Gene Service Market Challenges
- 5.3.4 Gene Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Gene Service Players by Revenue
- 6.1.1 Global Top Gene Service Players by Revenue (2021-2026)
- 6.1.2 Global Gene Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Gene Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Gene Service Head Office and Area Served
- 6.4 Global Gene Service Players, Product Type & Application
- 6.5 Global Gene Service Manufacturers Established Date
- 6.6 Global Gene Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Gene Service Market Size (2021-2032)
- 7.2 North America Gene Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Gene Service Market Size by Country (2021-2026)
- 7.4 North America Gene Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Gene Service Market Size (2021-2032)
- 8.2 Europe Gene Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Gene Service Market Size by Country (2021-2026)
- 8.4 Europe Gene Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Gene Service Market Size (2021-2032)
- 9.2 Asia-Pacific Gene Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Gene Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Gene Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Gene Service Market Size (2021-2032)
- 10.2 South America Gene Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Gene Service Market Size by Country (2021-2026)
- 10.4 South America Gene Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Gene Service Market Size (2021-2032)
- 11.2 Middle East & Africa Gene Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Gene Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Gene Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 LipExoGen Biotech
- 12.1.1 LipExoGen Biotech Company Information
- 12.1.2 LipExoGen Biotech Business Overview
- 12.1.3 LipExoGen Biotech Revenue in Gene Service Business (2021-2026)
- 12.1.4 LipExoGen Biotech Gene Service Product Portfolio
- 12.1.5 LipExoGen Biotech Recent Developments
- 12.2 Synbio Technologies
- 12.2.1 Synbio Technologies Company Information
- 12.2.2 Synbio Technologies Business Overview
- 12.2.3 Synbio Technologies Revenue in Gene Service Business (2021-2026)
- 12.2.4 Synbio Technologies Gene Service Product Portfolio
- 12.2.5 Synbio Technologies Recent Developments
- 12.3 Genscript Biotech Corporation
- 12.3.1 Genscript Biotech Corporation Company Information
- 12.3.2 Genscript Biotech Corporation Business Overview
- 12.3.3 Genscript Biotech Corporation Revenue in Gene Service Business (2021-2026)
- 12.3.4 Genscript Biotech Corporation Gene Service Product Portfolio
- 12.3.5 Genscript Biotech Corporation Recent Developments
- 12.4 Creative Biogene
- 12.4.1 Creative Biogene Company Information
- 12.4.2 Creative Biogene Business Overview
- 12.4.3 Creative Biogene Revenue in Gene Service Business (2021-2026)
- 12.4.4 Creative Biogene Gene Service Product Portfolio
- 12.4.5 Creative Biogene Recent Developments
- 12.5 GENEWIZ
- 12.5.1 GENEWIZ Company Information
- 12.5.2 GENEWIZ Business Overview
- 12.5.3 GENEWIZ Revenue in Gene Service Business (2021-2026)
- 12.5.4 GENEWIZ Gene Service Product Portfolio
- 12.5.5 GENEWIZ Recent Developments
- 12.6 Bio-Techne
- 12.6.1 Bio-Techne Company Information
- 12.6.2 Bio-Techne Business Overview
- 12.6.3 Bio-Techne Revenue in Gene Service Business (2021-2026)
- 12.6.4 Bio-Techne Gene Service Product Portfolio
- 12.6.5 Bio-Techne Recent Developments
- 12.7 Charles River Laboratories
- 12.7.1 Charles River Laboratories Company Information
- 12.7.2 Charles River Laboratories Business Overview
- 12.7.3 Charles River Laboratories Revenue in Gene Service Business (2021-2026)
- 12.7.4 Charles River Laboratories Gene Service Product Portfolio
- 12.7.5 Charles River Laboratories Recent Developments
- 12.8 Geneservice
- 12.8.1 Geneservice Company Information
- 12.8.2 Geneservice Business Overview
- 12.8.3 Geneservice Revenue in Gene Service Business (2021-2026)
- 12.8.4 Geneservice Gene Service Product Portfolio
- 12.8.5 Geneservice Recent Developments
- 12.9 Boston Medical Center
- 12.9.1 Boston Medical Center Company Information
- 12.9.2 Boston Medical Center Business Overview
- 12.9.3 Boston Medical Center Revenue in Gene Service Business (2021-2026)
- 12.9.4 Boston Medical Center Gene Service Product Portfolio
- 12.9.5 Boston Medical Center Recent Developments
- 12.10 DefiGEN
- 12.10.1 DefiGEN Company Information
- 12.10.2 DefiGEN Business Overview
- 12.10.3 DefiGEN Revenue in Gene Service Business (2021-2026)
- 12.10.4 DefiGEN Gene Service Product Portfolio
- 12.10.5 DefiGEN Recent Developments
- 12.11 NHS England
- 12.11.1 NHS England Company Information
- 12.11.2 NHS England Business Overview
- 12.11.3 NHS England Revenue in Gene Service Business (2021-2026)
- 12.11.4 NHS England Gene Service Product Portfolio
- 12.11.5 NHS England Recent Developments
- 12.12 Integrated DNA Technologies
- 12.12.1 Integrated DNA Technologies Company Information
- 12.12.2 Integrated DNA Technologies Business Overview
- 12.12.3 Integrated DNA Technologies Revenue in Gene Service Business (2021-2026)
- 12.12.4 Integrated DNA Technologies Gene Service Product Portfolio
- 12.12.5 Integrated DNA Technologies Recent Developments
- 12.13 Blossom
- 12.13.1 Blossom Company Information
- 12.13.2 Blossom Business Overview
- 12.13.3 Blossom Revenue in Gene Service Business (2021-2026)
- 12.13.4 Blossom Gene Service Product Portfolio
- 12.13.5 Blossom Recent Developments
- 12.14 Aldevron
- 12.14.1 Aldevron Company Information
- 12.14.2 Aldevron Business Overview
- 12.14.3 Aldevron Revenue in Gene Service Business (2021-2026)
- 12.14.4 Aldevron Gene Service Product Portfolio
- 12.14.5 Aldevron Recent Developments
- 12.15 Biocytogen
- 12.15.1 Biocytogen Company Information
- 12.15.2 Biocytogen Business Overview
- 12.15.3 Biocytogen Revenue in Gene Service Business (2021-2026)
- 12.15.4 Biocytogen Gene Service Product Portfolio
- 12.15.5 Biocytogen Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst